AVAglio: A phase III trial of bevacizumab added to standard radiotherapy and temozolomide in patients with newly diagnosed glioblastoma.
O. L. Chinot
Consultant or Advisory Role - Roche
Research Funding - Roche
W. Wick
Consultant or Advisory Role - Roche/Genentech
F. Saran
Consultant or Advisory Role - Roche
W. P. Mason
Consultant or Advisory Role - Roche
R. Henriksson
Consultant or Advisory Role - Roche
Honoraria - Roche
R. Nishikawa
Honoraria - Merck
A. H. Zeaiter
Employment or Leadership Position - Roche
N. Moore
Employment or Leadership Position - Roche
Stock Ownership - Roche
A. Das
Employment or Leadership Position - Roche/Genentech
Stock Ownership - Roche
T. F. Cloughesy
Consultant or Advisory Role - Roche
Honoraria - Roche/Genentech
Research Funding - Genentech
Expert Testimony - Genentech